For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230817:nRSQ5668Ja&default-theme=true
RNS Number : 5668J Omega Diagnostics Group PLC 17 August 2023
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company")
Board Appointment
Omega (AIM: ODX), the specialist medical diagnostics company focused on
industry-leading Health and Nutrition products, is pleased to announce the
appointment of Carolyn Rand to the Board as an independent Non-Executive
Director, with immediate effect.
Carolyn is a board professional with considerable experience in financial and
business leadership, governance and strategy planning across public and
private enterprises. Her current responsibilities include being Non-Executive
Director and Audit Committee Chair for AIM-quoted global Technology business
PCI-Pal plc, Non-Executive Director and Audit Committee Chair for AIM-quoted
global technology business IQGeo Group plc, and Governor of the College of
West Anglia. Throughout her career, Carolyn has held executive positions
within high-growth technology and scientific businesses including as CFO of
AIM-quoted payments technology business Bango plc, CFO of Zinwave, CEO of
Isogenica. Carolyn is a Fellow of the Chartered Institute of Management
Accountants having served as Regional Chair.
Commenting, Simon Douglas, Chairman, said: "We welcome Carolyn to the board
and look forward to adding her skillset and experience to Omega as we drive
the business forward".
Contacts:
Omega Diagnostics Group PLC www.omegadx.com (http://www.omegadx.com/)
Jag Grewal, Chief Executive Officer via Walbrook PR
finnCap Ltd Tel: 020 7220 0500
Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance)
Nigel Birks / Harriet Ward (ECM)
Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.com (mailto:omega@walbrookpr.com)
Paul McManus / Lianne Applegarth Mob: 07980 541 893 / 07584 391 303
Sam Allen Mob: 07502 558 258
About Omega Diagnostics Group PLC
Omega (AIM: ODX) is a specialist medical diagnostics company focused on
industry-leading Health and Nutrition products.
www.omegadx.com (http://www.omegadx.com/)
Regulatory disclosures
The following information is disclosed pursuant to Rule 17 and Schedule Two
paragraph (g) of the AIM Rules for Companies in relation to Carolyn Ann Rand,
aged 59:
Carolyn Rand holds or has held the following directorships/partnerships in the
past five years:
Current directorships/partnerships Past directorships/partnerships
IQGEO Group Plc Audiens SRL
PCI-Pal Plc Bango.net Limited
Advanced Business Finance Limited Bango Inc
Bango KK
Bango Plc
Carolyn is also currently a governor of the College of West Anglia.
Carolyn has no beneficial interest in the ordinary shares of the Company.
The Company confirms that there are no other disclosures to be made pursuant
to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies with
respect to Carolyn Rand.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOAZZGMRMVGGFZZ